Literature DB >> 7319129

Quantitative thermal imaging to assess inositol nicotinate treatment for Raynaud's syndrome.

E F Ring, L O Porto, P A Bacon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7319129     DOI： 10.1177/030006058100900601

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  4 in total

1.  Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

Authors:  N J McHugh; M Csuka; H Watson; G Belcher; A Amadi; E F Ring; C M Black; P J Maddison
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

Review 2.  Pharmacotherapy of Raynaud's phenomenon.

Authors:  J J Belch; M Ho
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

3.  Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Authors:  S J Hawkins; C M Black; N D Hall; A McGregor; E F Ring; P J Maddison
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin.

Authors:  S Shawket; C Dickerson; B Hazleman; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.